news about tirzepatide 🚨 BREAKING COMPOUND GLP-1 #tirzepatide #semaglutide FDA says the tirzepatide weight-loss

Compounded semaglutide has not undergone the same clinical trial rigor as brand-name Ozempic, so a patient choosing this route is taking on more risk and must rely on their own research to ensure safety and efficacy. If you cant afford name-brand Ozempic, Tchang says there are other possibilities for weight loss meds

If you want help deciding whether a personalized program makes sense for your goals, you can take the free assessment quiz

August 29 Product: Emergent BioSolutions ACAM2000 Indication: Mpox There is a second vaccine available in the battle against mpox after the FDA expanded its authorization for Emergent BioSolutions smallpox vaccine ACAM2000 to prevent infection in individuals deemed at high risk of the disease

HR 0.26 (95% CI 0.080.80, p = 0.012)